Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-10-14
1999-06-01
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
A61K 3170
Patent
active
059088346
ABSTRACT:
The use of ester and/or amide derivatives of partricin A and/or B to inhibit or forestall the growth of yeasts and molds in cell cultures of animal or vegetable origin, including hybridomas and cells whose DNA was modified. This use consists in adding the afore-said derivatives to the cell cultures in concentrations such as to inhibit the growth of yeast and molds but such as not to be toxic for the cell cultures themselves. The invention can be made use of, for instance, in the production of vaccines and in the conservation of organs and tissues intended for transplantation.
REFERENCES:
patent: 3780173 (1973-12-01), Bruzzese et al.
patent: 3961047 (1976-06-01), Bruzzese et al.
patent: 5296597 (1994-03-01), Bruzzese et al.
patent: 5298495 (1994-03-01), Bruzzese et al.
Samson Wright's Applied Physiology, Eleventh Ed., C.A. Keele, Ed., Oxford Univ. Press, London, p. 64, 1965.
P.B. Weisz, The Science of Biology, McGraw-Hill, New York, pp. 439-440, 1959.
T. Bruzzese et al, Eur. J. Med. Chem., vol. 31, pp. 965 and 972 (1996).
Henley III Raymond
Prospa B.V.
LandOfFree
Partricin derivatives in the prophylactic and/or curative treatm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Partricin derivatives in the prophylactic and/or curative treatm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Partricin derivatives in the prophylactic and/or curative treatm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-955019